Artivion director awarded 7,576 shares
Burbank Jeffrey H reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Burbank Jeffrey H reported acquisition or exercise transactions in this Form 4 filing.
ARTIVION, INC. director Jeffrey H. Burbank received a grant of 7,576 shares of Common Stock on May 18, 2026, at no purchase price. The RSA grant is scheduled to vest on May 18, 2027, under the company’s Equity and Cash Incentive Plan. Following this award, he directly holds 61,372 shares of Artivion stock.
Positive
- None.
Negative
- None.
Insights
Director receives time-vested equity grant as routine compensation.
Director Jeffrey H. Burbank was granted 7,576 shares of ARTIVION, INC. Common Stock at no purchase price, characterized as a grant or award under the company’s Equity and Cash Incentive Plan. This is compensation-related, not an open-market purchase.
The RSA grant vests on May 18, 2027, meaning the shares are subject to continued-service or similar conditions until that date. After the award, Burbank holds 61,372 shares directly, indicating this filing reflects ongoing equity-based compensation rather than a change in trading sentiment.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 7,576 | $0.00 | $0.00 |
Footnotes (1)
- F1. RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.
Key Figures
Key Terms
RSA Grant financial
Equity and Cash Incentive Plan financial
Form 4 regulatory
transaction code "A" regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Artivion (AORT) director Jeffrey Burbank report in this Form 4?
Was the Artivion (AORT) Form 4 transaction a market purchase or sale?
What does transaction code "A" mean in the Artivion (AORT) Form 4?
AI-generated analysis. How Rhea-AI works. Not financial advice.